These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17547117)

  • 1. [Non-steroid gastropathy combined with Helicobacter pylori: current problems].
    Akhmedov VA; Vinzhegina VA; Sudakova AN; Rozenblit EI
    Eksp Klin Gastroenterol; 2007; (1):64-6. PubMed ID: 17547117
    [No Abstract]   [Full Text] [Related]  

  • 2. [Non-steroid gastropathy: particular features of treatment].
    Vasil'ev IuV
    Eksp Klin Gastroenterol; 2007; (1):56-9. PubMed ID: 17547115
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
    Salentijn GJ
    Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2340. PubMed ID: 10589227
    [No Abstract]   [Full Text] [Related]  

  • 4. [NSAID-induced damage to the gastrointestinal mucosa].
    Rodonezhskaia EV; Kharchenko NV
    Lik Sprava; 2001; (4):179-80. PubMed ID: 11692710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori: a risk and severity factor of non-steroidal anti-inflammatory drug induced gastropathy.
    Heresbach D; Raoul JL; Bretagne JF; Minet J; Donnio PY; Ramée MP; Siproudhis L; Gosselin M
    Gut; 1992 Dec; 33(12):1608-11. PubMed ID: 1487160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-steroidal anti-inflammatory drugs request parity with Helicobacter pylori.
    Ladwa M; Takeuchi K; Bjarnason I
    Scand J Gastroenterol; 2006 Apr; 41(4):373-5. PubMed ID: 16635902
    [No Abstract]   [Full Text] [Related]  

  • 7. Helicobacter pylori and NSAIDS--more questions than answers.
    Ryan MJ
    Am J Gastroenterol; 1991 Aug; 86(8):1090-1. PubMed ID: 1858749
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gastropathy caused by nonsteriod anti-inflammatory drugs: from understanding of development mechanisms to planning strategy of treatment and prophylaxis].
    Akhmedov VA; Vinzhegina VA; Sudakova AN; Rozenblit EI
    Ter Arkh; 2007; 79(2):81-5. PubMed ID: 17460975
    [No Abstract]   [Full Text] [Related]  

  • 9. [Helicobacter pylori and non-steroidal anti-inflammatory agents].
    Knoflach P
    Acta Med Austriaca; 2000; 27(4):126-8. PubMed ID: 10989682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acid-related diseases. Should H. pylori be eradicated in patients who will receive prolonged NSAID treatment?].
    Lanas Arbeloa A
    Gastroenterol Hepatol; 2009 Mar; 32(3):173-4. PubMed ID: 19268192
    [No Abstract]   [Full Text] [Related]  

  • 11. [Helicobacter pylori infection and diseases of the stomach and duodenum].
    Svestka T; Krechler T; Brůha R; Jablonská M
    Cas Lek Cesk; 2004; 143(11):734-7. PubMed ID: 15628566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are patients at increased risk?
    Sloan J
    Can Fam Physician; 1998 Oct; 44():2065-6. PubMed ID: 9805153
    [No Abstract]   [Full Text] [Related]  

  • 13. Definitions and classification of dyspepsia: pH, Helicobacter pylori, non-steroidal anti-inflammatory drugs--should we include gastro-oesophageal reflux disease?
    Bazzoli F
    Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():15-6, 21-4. PubMed ID: 15755270
    [No Abstract]   [Full Text] [Related]  

  • 14. Helicobacter pylori and portal hypertensive gastropathy.
    Guslandi M
    Am J Gastroenterol; 1997 Apr; 92(4):723. PubMed ID: 9128347
    [No Abstract]   [Full Text] [Related]  

  • 15. Loss of non-steroidal anti-inflammatory drug hypersensitivity after Helicobacter pylori eradication.
    Neynaber S; Berking C; Przybilla B
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):196-7. PubMed ID: 18507698
    [No Abstract]   [Full Text] [Related]  

  • 16. Safer NSAID strategies: consensus or contentious?
    Hawkey CJ
    Rheumatology (Oxford); 2008 Sep; 47(9):1265-6. PubMed ID: 18611921
    [No Abstract]   [Full Text] [Related]  

  • 17. [Helicobacter pylori infection in patients with liver cirrhosis: diagnostics and problems of therapy].
    Iakovenko AV; Grigor'ev PIa; Obukhovskiĭ BI; Mel'nikova SV; Guseĭnova LA; Mardar'eva SV; Agafonova NA; Prianishnikova AS; Soluianova IP; Gioeva IZ; Iakovenko EP
    Eksp Klin Gastroenterol; 2006; (1):84-8. PubMed ID: 16866252
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drugs induced gastropathy: endoscopic findings in rheumatic patients.
    Rodríguez W; Irrizarry JF; Latimer C
    Bol Asoc Med P R; 1988 Oct; 80(10):366-8. PubMed ID: 3265062
    [No Abstract]   [Full Text] [Related]  

  • 19. Peptic ulcer disease.
    Harbison SP; Dempsey DT
    Curr Probl Surg; 2005 Jun; 42(6):346-454. PubMed ID: 15988415
    [No Abstract]   [Full Text] [Related]  

  • 20. Helicobacter pylori-associated protein-losing hypertrophic gastropathy with hypercholesterolemia.
    Kapsoritakis AN; Potamianos S; Matrella E; Koukouraki S; Oeconomaki E; Tzardi M; Karkavitsas N; Kouroumalis EA
    Dig Dis Sci; 1999 Sep; 44(9):1843-7. PubMed ID: 10505723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.